Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Sell
50
MURGY Quote, Financials, Valuation and Earnings
Last price:
$13.33
Seasonality move
:
4.57%
Day range:
$13.28 - $13.48
52-week range:
$9.29 - $14.10
Dividend yield:
3.4%
P/E ratio:
17.71x
P/S ratio:
1.99x
P/B ratio:
2.44x
Volume:
154.7K
Avg. volume:
241.9K
1-year change:
34.56%
Market cap:
$87.6B
Revenue:
$45.8B
EPS (TTM):
$0.75
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $67B | $76.3B | $42B | $43.2B | $45.8B | |
| Revenue Growth (YoY) | 4.06% | 12.84% | -45% | 2.89% | 6% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.2B | $3.6B | $8.2B | $9.3B | $9.7B | |
| Other Inc / (Exp) | $575.6M | $969M | $1.1B | -$316.1M | $189.4M | |
| Operating Expenses | $5B | $5.3B | $10.4B | $12B | $12.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $387.1M | $398.7M | $301.6M | $320.5M | $355M | |
| EBT. Incl. Unusual Items | $1.7B | $4.9B | $10.6B | $7.7B | $9.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $307.2M | $653.1M | $1.4B | $1B | $2.3B | |
| Net Income to Company | $1.4B | $3.5B | $5.6B | $5B | $6.1B | |
| Minority Interest in Earnings | -- | $1.2M | $3.2M | $9.7M | $15.2M | |
| Net Income to Common Excl Extra Items | $1.4B | $3.5B | $5.6B | $5B | $6.2B | |
| Basic EPS (Cont. Ops) | $0.20 | $0.50 | $0.80 | $0.73 | $0.93 | |
| Diluted EPS (Cont. Ops) | $0.20 | $0.50 | $0.80 | $0.73 | $0.93 | |
| Weighted Average Basic Share | $7B | $7B | $7B | $6.8B | $6.6B | |
| Weighted Average Diluted Share | $7B | $7B | $7B | $6.8B | $6.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.1B | $5.3B | $10.9B | $8B | $9.8B | |
| Revenue (Reported) | $67B | $76.3B | $42B | $43.2B | $45.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.1B | $5.3B | $10.9B | $8B | $9.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.9B | $15.6B | $16.9B | $18.7B | $17.3B | |
| Revenue Growth (YoY) | 19.65% | -11.48% | 8.59% | 10.61% | -7.7% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $2B | $2.1B | $2.4B | $2.4B | |
| Other Inc / (Exp) | -$27.7M | $248M | -$155.7M | $300.9M | -$532.4M | |
| Operating Expenses | $4B | $2.5B | $2.6B | $3B | $2.9B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $71.1M | $52.7M | $45.1M | $45.6M | $60M | |
| EBT. Incl. Unusual Items | $847.1M | $2B | $1.9B | $3.1B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $137.4M | $378.2M | $488.7M | $797.3M | $329.3M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $6M | -$6.7M | $5.4M | -- | $1.1M | |
| Net Income to Common Excl Extra Items | $715.8M | $1.7B | $1.4B | $2.3B | $1.2B | |
| Basic EPS (Cont. Ops) | $0.10 | $0.24 | $0.20 | $0.34 | $0.18 | |
| Diluted EPS (Cont. Ops) | $0.10 | $0.24 | $0.20 | $0.34 | $0.18 | |
| Weighted Average Basic Share | $7B | $7B | $6.9B | $6.7B | $6.6B | |
| Weighted Average Diluted Share | $7B | $7B | $6.9B | $6.7B | $6.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $918.2M | $2.1B | $1.9B | $3.1B | $1.5B | |
| Revenue (Reported) | $17.9B | $15.6B | $16.9B | $18.7B | $17.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $918.2M | $2.1B | $1.9B | $3.1B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $70B | $74.7B | $41.5B | $44.7B | $44.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $8.4B | $9.6B | $9.8B | |
| Other Inc / (Exp) | $401.7M | $1.2B | $727.8M | $146.8M | -$547.2M | |
| Operating Expenses | -$1.5B | -$2.5B | $10.6B | $12.3B | $12.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $440.9M | $420.1M | $290.8M | $320.2M | $368.4M | |
| EBT. Incl. Unusual Items | $2B | $6.9B | $7.6B | $8.4B | $7.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $143.4M | $896.3M | $1.5B | $1.3B | $1.8B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $5.9M | -$10.2M | $14.5M | $5.4M | $16M | |
| Net Income to Common Excl Extra Items | $1.8B | $4.4B | $5.3B | $5.9B | $5B | |
| Basic EPS (Cont. Ops) | $0.26 | $0.63 | $0.77 | $0.88 | $0.75 | |
| Diluted EPS (Cont. Ops) | $0.26 | $0.63 | $0.77 | $0.88 | $0.75 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.4B | $7.3B | $7.9B | $8.7B | $7.9B | |
| Revenue (Reported) | $70B | $74.7B | $41.5B | $44.7B | $44.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.4B | $7.3B | $7.9B | $8.7B | $7.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.9B | $15.6B | $16.9B | $18.7B | $17.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $2B | $2.1B | $2.4B | $2.4B | |
| Other Inc / (Exp) | -$27.7M | $248M | -$155.7M | $300.9M | -$532.4M | |
| Operating Expenses | $4B | $2.5B | $2.6B | $3B | $2.9B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $71.1M | $52.7M | $45.1M | $45.6M | $60M | |
| EBT. Incl. Unusual Items | $847.1M | $2B | $1.9B | $3.1B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $137.4M | $378.2M | $488.7M | $797.3M | $329.3M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $6M | -$6.7M | $5.4M | -- | $1.1M | |
| Net Income to Common Excl Extra Items | $715.8M | $1.7B | $1.4B | $2.3B | $1.2B | |
| Basic EPS (Cont. Ops) | $0.10 | $0.24 | $0.20 | $0.34 | $0.18 | |
| Diluted EPS (Cont. Ops) | $0.10 | $0.24 | $0.20 | $0.34 | $0.18 | |
| Weighted Average Basic Share | $7B | $7B | $6.9B | $6.7B | $6.6B | |
| Weighted Average Diluted Share | $7B | $7B | $6.9B | $6.7B | $6.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $918.2M | $2.1B | $1.9B | $3.1B | $1.5B | |
| Revenue (Reported) | $17.9B | $15.6B | $16.9B | $18.7B | $17.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $918.2M | $2.1B | $1.9B | $3.1B | $1.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.1B | $9.9B | $10B | $9.5B | $9.6B | |
| Short Term Investments | $191.1B | $183.9B | -- | $184.9B | $184.6B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | $12.5M | |
| Prepaid Expenses | $831.5M | $833.3M | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $235.3B | $228.4B | $16.6B | $17.4B | $16.5B | |
| Property Plant And Equipment | $10.8B | $10.4B | $2.3B | $2.3B | $2.1B | |
| Long-Term Investments | $214.1B | $207B | $227.9B | $237.1B | $234.4B | |
| Goodwill | $3.4B | $3.5B | $3.5B | $3.5B | $3.6B | |
| Other Intangibles | $1.5B | $1.5B | $1.1B | $1.1B | $929.2M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $366.5B | $353.7B | $288.9B | $302.7B | $298.1B | |
| Accounts Payable | $17.7B | $17.9B | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $20B | $20B | $1.7B | $2.9B | $2.3B | |
| Long-Term Debt | $7.8B | $7.2B | $5.1B | $5.2B | $6.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $329.6B | $318.7B | $259.7B | $269.7B | $264.1B | |
| Common Stock | $9.1B | $8.4B | $8B | $8.2B | $7.7B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $36.8B | $34.9B | $29.1B | $32.8B | $34B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $123M | $131.3M | $163M | $134.9M | $108.2M | |
| Total Equity | $36.9B | $35B | $29.2B | $32.9B | $34.1B | |
| Total Liabilities and Equity | $366.5B | $353.7B | $288.9B | $302.7B | $298.1B | |
| Cash and Short Terms | $202.3B | $193.9B | $10B | $9.5B | $9.6B | |
| Total Debt | $7.8B | $7.2B | $5.1B | $5.2B | $6.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.3B | $6B | $6.3B | $6.5B | $5.9B | |
| Short Term Investments | $182.4B | $172.1B | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | $10.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $222.8B | $216B | $12.6B | $14.9B | $13.2B | |
| Property Plant And Equipment | $7.7B | $7.7B | $585.6M | $542.1M | $881M | |
| Long-Term Investments | $207.7B | $199.8B | $227.3B | $235.6B | $243.2B | |
| Goodwill | $3.5B | $3.5B | $3.5B | $3.5B | $3.6B | |
| Other Intangibles | $1.5B | $1.4B | $1.1B | $1.1B | $940.5M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $352.8B | $345.7B | $287.4B | $297.7B | $305.9B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.1B | $2B | $1.8B | $3.1B | $2.5B | |
| Long-Term Debt | $6.3B | $6B | $5.2B | $5.2B | $6.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $318.3B | $314.7B | $256.7B | $264B | $269.8B | |
| Common Stock | $8.7B | $8.3B | $8.1B | $8B | $8B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $111.4M | $123.9M | $145M | $128.5M | $187.2M | |
| Total Equity | $34.5B | $31B | $30.7B | $33.7B | $36.1B | |
| Total Liabilities and Equity | $352.8B | $345.7B | $287.4B | $297.7B | $305.9B | |
| Cash and Short Terms | $189.6B | $178.1B | $6.3B | $6.5B | $5.9B | |
| Total Debt | $6.3B | $6B | $5.2B | $5.2B | $6.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.4B | $3.5B | $5.6B | $5B | $6.1B | |
| Depreciation & Amoritzation | -- | -- | $3B | $343.2M | $405.9M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8.2B | $6.2B | $4.2B | $2.8B | $3.4B | |
| Capital Expenditures | -- | -- | $368.1M | $374.6M | $342M | |
| Cash Acquisitions | -- | -$181M | $39M | -$31.4M | -$317.1M | |
| Cash From Investing | -$7B | -$4.5B | -$284.7M | -$356.2M | -$546.6M | |
| Dividends Paid (Ex Special Dividend) | -$1.6B | -$1.6B | -$1.6B | -$1.7B | -$2.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $1.6B | |
| Long-Term Debt Repaid | -- | -- | -$482M | -$145.1M | -$152.6M | |
| Repurchase of Common Stock | -- | -- | -$638M | -$1.1B | -$1.6B | |
| Other Financing Activities | $1.2B | -$358.5M | -$96M | -$243.6M | -$141.8M | |
| Cash From Financing | -$368.9M | -$2B | -$2.8B | -$3.2B | -$2.4B | |
| Beginning Cash (CF) | $5.7B | $6.6B | $5.7B | $7B | $6.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $869.1M | -$323M | $1.1B | -$832.5M | $443.8M | |
| Ending Cash (CF) | $6.4B | $6.5B | $6.8B | $6.1B | $6.6B | |
| Levered Free Cash Flow | $8.2B | $6.2B | $3.8B | $2.4B | $3.1B | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $879.7M | $706.2M | $1.6B | $983.3M | $807.3M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $4.8B | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $76.5M | $817.6M | -$568.3M | $446.7M | $1.1B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | $24.7M | $2M | -$78.5M | -$21.7M | $24.5M | |
| Cash From Investing | -$2B | -$421.6M | $162.5M | -$253.3M | -$970.7M | |
| Dividends Paid (Ex Special Dividend) | $15.7M | -$39.5M | -$3.2M | -$5.8M | $2.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $487.6M | -- | -- | -- | -- | |
| Other Financing Activities | -$484.8M | -$7.6M | -$415.9M | -$410.8M | -$376.2M | |
| Cash From Financing | $18.5M | $108.5M | -$418.8M | -$416.6M | -$374M | |
| Beginning Cash (CF) | $5.4B | $3.1B | $4.4B | $4.1B | $4.7B | |
| Foreign Exchange Rate Adjustment | $61.9M | $13.7M | $147.2M | $11.5M | -$31.4M | |
| Additions / Reductions | -$1.9B | $504.5M | -$824.7M | -$223.1M | -$203.8M | |
| Ending Cash (CF) | $3.5B | $3.7B | $3.7B | $3.9B | $4.5B | |
| Levered Free Cash Flow | $76.5M | $817.6M | -$568.3M | $446.7M | $1.1B | |
| Period Ending | 2012-09-30 | 2013-09-30 | 2014-09-30 | 2015-09-30 | 2016-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.3B | $3.5B | $4.8B | $3.6B | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $6.4B | $4.3B | $9B | $4.1B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$266.6M | -$62.9M | -$207M | -$80.6M | $24.5M | |
| Cash From Investing | -$7.6B | -$196.2M | -$6.2B | -$425.5M | -- | |
| Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.7B | -$1.7B | -$1.4B | $2.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $199.1M | -$1.5B | -$1.9B | -$1.2B | -- | |
| Cash From Financing | -$689.1M | -$2.9B | -$3.6B | -$2.6B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2B | $1.2B | -$742.5M | $1B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $6.4B | $4.3B | $9B | $4.1B | -- | |
| Period Ending | 2021-07-19 | 2022-07-19 | 2023-07-19 | 2024-07-19 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get MURGY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MURGY
Sector
P/E ratio
17.71x
12.21x
PEG ratio
0.54x
0.40x
P/B ratio
2.44x
1.10x
Price / LTM sales
1.99x
2.66x
Growth Metrics
MURGY
Sector
Revenue growth
-7.7%
5.02%
Earnings growth
-48.77%
2.75%
Revenue (5-year growth)
-6.77%
5.15%
Earnings forecast
--
$0.61
Profitability
MURGY
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
12.2%
5.2%
Return on assets
1.65%
0.97%
Return on equity
14.48%
9.24%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
12
Balance Sheet
MURGY
Sector
Total cash
$5.9B
$451.2M
Short term investments
$184.6B
$220.9M
Total assets
$298.1B
$3.8B
Long term debt
$6.8B
$285.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
